General MedicationsORALStandard
EFAVIRENZ
EFAVIRENZ
Standard Dose
100MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview EFAVIRENZ is listed in Drugs@FDA under application 078064 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient EFAVIRENZ Form and strength CAPSULE;ORAL - 100MG Sponsor AUROBINDO PHARMA Submission history Latest submission status date: 2024-06-20 00:00:00.
Structured Monograph
Clinical summary
Approval overview EFAVIRENZ is listed in Drugs@FDA under application 078064 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient EFAVIRENZ Form and strength CAPSULE;ORAL - 100MG Sponsor AUROBINDO PHARMA Submission history Latest submission status date: 2024-06-20 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.